{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:01:03Z","timestamp":1791900063594,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lfs.2026.124420","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:56:57Z","timestamp":1777647417000},"page":"124420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting P2X purinergic receptors with suramin alleviates rotenone-induced Parkinson's-like pathology via modulation of mitophagy and NLRP3-pyroptosis: Comparison with metformin"],"prefix":"10.1016","volume":"397","author":[{"given":"Mohamed S.","family":"Attia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy N.","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa I.","family":"Shabayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebatallah A.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"El-Sawalhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124420_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137596","article-title":"Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease","volume":"820","author":"Rajan","year":"2024","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2026.124420_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108285","article-title":"In-silico screening to identify phytochemical inhibitor for hP2X7: A crucial inflammatory cell death mediator in Parkinson's disease","volume":"115","author":"Khan","year":"2025","journal-title":"Comput. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2026.124420_bb0015","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/biom11040612","article-title":"Treatment options for motor and non-motor symptoms of Parkinson\u2019s disease","volume":"11","author":"Church","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2026.124420_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110346","article-title":"Antiplatelet therapy as a novel approach in Parkinson's disease: Repositioning Ticagrelor to alleviate rotenone-induced parkinsonism via modulation of ER stress, apoptosis, and autophagy","volume":"269","author":"Muneeb","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2026.124420_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176743","article-title":"Cytarabine prevents neuronal damage by enhancing AMPK to stimulate PINK1\/Parkin-involved mitophagy in Parkinson's disease model","volume":"977","author":"Li","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12035-025-05389-0","article-title":"Nrf2-Keap1 Pathway and NLRP3 Inflammasome in Parkinson's Disease: Mechanistic Crosstalk and Therapeutic Implications","volume":"63","author":"Jain","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124420_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102872","article-title":"Understanding the influence of TLR-mediated immune system on necroptosis-induced neurodegeneration in Parkinson\u2019s disease","volume":"112","author":"Jadhav","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10367","article-title":"Alzheimer's and Parkinson's disease therapies in the clinic","volume":"8","author":"Chopade","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.lfs.2026.124420_bb0045","article-title":"Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"23","key":"10.1016\/j.lfs.2026.124420_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314758","article-title":"Purinergic Receptors P2X7 and P2X4 as Markers of Disease Progression in the rd10 Mouse Model of Inherited Retinal Dystrophy","volume":"23","author":"Mart\u00ednez-Gil","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124420_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2021.104636","article-title":"Immunohistochemical evidence of P2X7R, P2X4R and CaMKK2 in pyramidal neurons of frontal cortex does not align with Alzheimer's disease","volume":"120","author":"Gaff","year":"2021","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.lfs.2026.124420_bb0060","article-title":"Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases","volume":"15","author":"Zheng","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.lfs.2026.124420_bb0065","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.neurobiolaging.2015.03.015","article-title":"P2X7 receptor is critical in \u03b1-synuclein\u2013mediated microglial NADPH oxidase activation","volume":"36","author":"Jiang","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.lfs.2026.124420_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/cells13020161","article-title":"Modulation of microglial function by ATP-gated P2X7 receptors: studies in rat, mice and human","volume":"13","author":"Tewari","year":"2024","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.lfs.2026.124420_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113959","article-title":"P2X7 Receptor is Involved in Mitochondrial Dysfunction Induced by Extracellular Alpha Synuclein in Neuroblastoma SH-SY5Y Cells","volume":"21","author":"Wilkaniec","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124420_bb0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.01.045","article-title":"The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis","volume":"81","author":"Carmo","year":"2014","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.lfs.2026.124420_bb0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3727\/096368917X695227","article-title":"Brilliant Blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson\u2019s disease","volume":"26","author":"Ferrazoli","year":"2017","journal-title":"Cell Transplant."},{"key":"10.1016\/j.lfs.2026.124420_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.580068","article-title":"P2X4R overexpression upregulates interleukin-6 and exacerbates 6-OHDA-induced dopaminergic degeneration in a rat model of PD","volume":"12","author":"Ma","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"7","key":"10.1016\/j.lfs.2026.124420_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070712","article-title":"Mitophagy in Parkinson's Disease: From Pathogenesis to Treatment","volume":"8","author":"Liu","year":"2019","journal-title":"Cells"},{"issue":"41","key":"10.1016\/j.lfs.2026.124420_bb0100","doi-asserted-by":"crossref","first-page":"21616","DOI":"10.1074\/jbc.M116.733410","article-title":"BNIP3 Protein Suppresses PINK1 Kinase Proteolytic Cleavage to Promote Mitophagy","volume":"291","author":"Zhang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124420_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101816","article-title":"Proteostasis in Parkinson\u2019s disease: Recent development and possible implication in diagnosis and therapeutics","volume":"84","author":"Kulkarni","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.lfs.2026.124420_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108963","article-title":"Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model","volume":"207","author":"Qiu","year":"2022","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/ADR-230128","article-title":"Dimethyl fumarate exerts a neuroprotective effect by enhancing mitophagy via the NRF2\/BNIP3\/PINK1 axis in the MPP+ iodide-induced Parkinson\u2019s disease mice model","volume":"8","author":"Pinjala","year":"2024","journal-title":"J. Alzheimers Dis. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0120","article-title":"Dexmedetomidine can enhance PINK1\/Parkin-mediated mitophagy in MPTP-induced PD mice model by activating AMPK","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.lfs.2026.124420_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000328516","article-title":"Resveratrol-activated AMPK\/SIRT1\/autophagy in cellular models of Parkinson\u2019s disease","volume":"19","author":"Wu","year":"2011","journal-title":"Neurosignals"},{"issue":"8","key":"10.1016\/j.lfs.2026.124420_bb0130","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/ene.14918","article-title":"P2X7 receptor\/NLRP3 inflammasome complex and \u03b1-synuclein in peripheral blood mononuclear cells: a prospective study in neo-diagnosed, treatment-na\u00efve Parkinson's disease","volume":"28","author":"Solini","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.lfs.2026.124420_bb0135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bbi.2020.10.010","article-title":"Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson\u2019s disease","volume":"91","author":"Qin","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.lfs.2026.124420_bb0140","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","article-title":"NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson's Disease","volume":"39","author":"Han","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10020-024-00917-5","article-title":"Parthenolide ameliorates 3-nitropropionic acid-induced Huntington's disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting","volume":"30","author":"Noureldeen","year":"2024","journal-title":"Mol. Med."},{"issue":"8","key":"10.1016\/j.lfs.2026.124420_bb0150","article-title":"Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 profiles in patients with Relapsing-Remitting Multiple Sclerosis: impact on disease activity and progression","volume":"vol. 13","author":"Attia","year":"2023","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-017-0904-8","article-title":"The role of microglial P2X7: modulation of cell death and cytokine release","volume":"14","author":"He","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.lfs.2026.124420_bb0160","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acschemneuro.1c00095","article-title":"Depression Induced by Chronic Unpredictable Mild Stress Increases Susceptibility to Parkinson's Disease in Mice via Neuroinflammation Mediated by P2X7 Receptor","volume":"12","author":"Ren","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.lfs.2026.124420_bb0165","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4103\/1673-5374.323077","article-title":"The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson\u2019s disease","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.lfs.2026.124420_bb0170","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1007\/s12035-024-04367-2","article-title":"Palmatine Ameliorates Motor Deficits and Dopaminergic Neuron Loss by Regulating NLRP3 Inflammasome through Mitophagy in Parkinson's Disease Model Mice","volume":"62","author":"Zhao","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124420_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156928","article-title":"Ciliatoside A attenuates neuroinflammation in Alzheimer's disease by activating mitophagy and inhibiting NLRP3 inflammasome activation","volume":"145","author":"Guo","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12991-023-00477-8","article-title":"Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder","volume":"22","author":"Hough","year":"2023","journal-title":"Ann. General Psychiatry"},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11481-025-10207-4","article-title":"Possible Interaction of Suramin with Thalamic P2X Receptors and NLRP3 Inflammasome Activation Alleviates Reserpine-Induced Fibromyalgia-Like Symptoms","volume":"20","author":"Mohamed","year":"2025","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00436-023-08027-7","article-title":"100 years since the publication of the suramin formula","volume":"123","author":"Steverding","year":"2023","journal-title":"Parasitol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2026.124420_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057380","article-title":"Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model","volume":"8","author":"Naviaux","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2026.124420_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.33","article-title":"Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy","volume":"4","author":"Naviaux","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.lfs.2026.124420_bb0205","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/acn3.424","article-title":"Low-dose suramin in autism spectrum disorder: a small, phase I\/II, randomized clinical trial","volume":"4","author":"Naviaux","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.lfs.2026.124420_bb0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00221-002-1251-1","article-title":"Suramin reduces infarct volume in a model of focal brain ischemia in rats","volume":"147","author":"Kharlamov","year":"2002","journal-title":"Exp. Brain Res."},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0215","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JAD-230600","article-title":"Impact of Suramin on Key Pathological Features of Sporadic Alzheimer\u2019s Disease-Derived Forebrain Neurons","volume":"98","author":"Culibrk","year":"2024","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"2020","key":"10.1016\/j.lfs.2026.124420_bb0220","article-title":"Therapeutic role of protein tyrosine phosphatase 1B in Parkinson\u2019s disease via antineuroinflammation and neuroprotection in vitro and in vivo","volume":"1","author":"Feng","year":"2020","journal-title":"Parkinsons Dis."},{"issue":"4\u20135","key":"10.1016\/j.lfs.2026.124420_bb0225","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14728222.2023.2206955","article-title":"Dapagliflozin modulates neuronal injury via instigation of LKB1\/p-AMPK\/GABA(B) R2 signaling pathway and suppression of the inflammatory cascade in an essential tremor rat model","volume":"27","author":"Kamel","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11481-025-10218-1","article-title":"Exploring Dapagliflozin's Influence on Autophagic Flux in Mania-like Behaviour: Insights from the LKB1\/AMPK\/LC3 Pathway in a Mouse Model","volume":"20","author":"Saleh","year":"2025","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2026.124420_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw047","article-title":"Metformin prevents dopaminergic neuron death in MPTP\/P-induced mouse model of Parkinson\u2019s disease via autophagy and mitochondrial ROS clearance","volume":"19","author":"Lu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.lfs.2026.124420_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110723","article-title":"Metformin alleviates cerebral ischemia\/reperfusion injury aggravated by hyperglycemia via regulating AMPK\/ULK1\/PINK1\/Parkin pathway-mediated mitophagy and apoptosis","volume":"384","author":"Guo","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2026.124420_bb0245","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fncel.2018.00440","article-title":"Divergent Effects of Metformin on an Inflammatory Model of Parkinson's Disease","volume":"12","author":"Tayara","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"8","key":"10.1016\/j.lfs.2026.124420_bb0250","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1139\/cjpp-2020-0373","article-title":"Metformin alleviates hydrogen peroxide-induced inflammation and oxidative stress via inhibiting P2X7R signaling in spinal cord tissue cells neurons","volume":"99","author":"Wang","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"34","key":"10.1016\/j.lfs.2026.124420_bb0255","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson\u2019s disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2026.124420_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112640","article-title":"Repurposing ezetimibe as a neuroprotective agent in a rotenone-induced Parkinson\u2019s disease model in rats: role of AMPK\/SIRT-1\/PGC-1\u03b1 signaling and autophagy","volume":"138","author":"Elesawy","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124420_bb0265","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/acschemneuro.0c00722","article-title":"Targeting ROS-dependent AKT\/GSK-3\u03b2\/NF-\u03baB and DJ-1\/Nrf2 pathways by dapagliflozin attenuates neuronal injury and motor dysfunction in rotenone-induced Parkinson\u2019s disease rat model","volume":"12","author":"Arab","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.lfs.2026.124420_bb0270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008389","article-title":"Metformin Improves Neurologic Outcome Via AMP-Activated Protein Kinase-Mediated Autophagy Activation in a Rat Model of Cardiac Arrest and Resuscitation","volume":"7","author":"Zhu","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"96","key":"10.1016\/j.lfs.2026.124420_bb0275","doi-asserted-by":"crossref","DOI":"10.3791\/52434-v","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","volume":"6","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.lfs.2026.124420_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110002","article-title":"Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson's disease in rats: Targeting the GRP78\/PERK\/eIF2\u03b1\/CHOP pathway and miR-211-5p","volume":"362","author":"Motawi","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2026.124420_bb0285","article-title":"Motor coordination and balance in rodents","volume":"Chapter 8","author":"Carter","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"issue":"4","key":"10.1016\/j.lfs.2026.124420_bb0290","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod","volume":"20","author":"Jones","year":"1968","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124420_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113716","article-title":"Crosstalk between SIRT1\/Nrf2 signaling and NLRP3 inflammasome\/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in Parkinson's disease","volume":"145","author":"Ghaith","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2026.124420_bb0300","series-title":"Handbook of histopathological and histochemical techniques: including museum techniques","author":"Culling","year":"2013"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2026.124420_bb0305","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"4","key":"10.1016\/j.lfs.2026.124420_bb0310","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.lfs.2026.124420_bb0315","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","article-title":"Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease","volume":"125","author":"Katila","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2026.124420_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.814999","article-title":"Microglial Activation Modulated by P2X4R in Ischemia and Repercussions in Alzheimer's Disease","volume":"13","author":"Castillo","year":"2022","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124420_bb0325","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1523\/ENEURO.0092-22.2022","article-title":"P2X7 receptor and purinergic signaling: orchestrating mitochondrial dysfunction in neurodegenerative diseases","volume":"9","author":"Zelentsova","year":"2022","journal-title":"eNeuro"},{"issue":"2","key":"10.1016\/j.lfs.2026.124420_bb0330","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11011-021-00879-1","article-title":"Neuroprotective effects of liraglutide against inflammation through the AMPK\/NF-\u03baB pathway in a mouse model of Parkinson\u2019s disease","volume":"37","author":"Cao","year":"2022","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0335","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12026-011-8203-4","article-title":"Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions","volume":"50","author":"Lenertz","year":"2011","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0340","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11033-022-07954-5","article-title":"Role of metformin in inflammation","volume":"50","author":"Feng","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0345","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15171\/jrip.2019.11","article-title":"Metformin and its anti-inflammatory and anti-oxidative effects; new concepts","volume":"8","author":"Dehkordi","year":"2018","journal-title":"J. Renal Inj. Prev."},{"issue":"12","key":"10.1016\/j.lfs.2026.124420_bb0350","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1039\/C7MT00257B","article-title":"Oxidative stress-induced increase of intracellular zinc in astrocytes decreases their functional expression of P2X7 receptors and engulfing activity","volume":"9","author":"Furuta","year":"2017","journal-title":"Metallomics"},{"issue":"4","key":"10.1016\/j.lfs.2026.124420_bb0355","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","article-title":"Metformin role in Parkinson\u2019s disease: a double-sword effect","volume":"479","author":"Alrouji","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2026.124420_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2026.121574","article-title":"Research progress on employing medicinal plants and their active compounds to target autophagic pathways for Parkinson\u2019s disease therapy","volume":"365","author":"Hu","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2026.124420_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-9081-9-13","article-title":"The role of autophagy in Parkinson's disease: rotenone-based modeling","volume":"9","author":"Xiong","year":"2013","journal-title":"Behav. Brain Funct."},{"issue":"3","key":"10.1016\/j.lfs.2026.124420_bb0370","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.molcel.2020.12.008","article-title":"Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53","volume":"81","author":"Jiang","year":"2021","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.lfs.2026.124420_bb0375","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12964-018-0293-3","article-title":"AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia","volume":"16","author":"Sekar","year":"2018","journal-title":"Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.lfs.2026.124420_bb0380","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s10787-026-02146-0","article-title":"Neuroinflammatory control of metabolism in huntington's disease: central role of P2\u00d77 receptor mediated redox lipid\/epigenetic crosstalk","volume":"34","author":"Bhatia","year":"2026","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.lfs.2026.124420_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114055","article-title":"Metformin attenuates early brain injury after subarachnoid hemorrhage in rats via AMPK-dependent mitophagy","volume":"353","author":"Zhang","year":"2022","journal-title":"Exp. Neurol."},{"issue":"15","key":"10.1016\/j.lfs.2026.124420_bb0390","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","article-title":"Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease","volume":"110","author":"Panicker","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2026.124420_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113608","article-title":"Pyroptosis mediated by Parkin-NLRP3 negative feedback loop contributed to Parkinson\u2019s disease induced by rotenone","volume":"143","author":"Zheng","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2026.124420_bb0400","article-title":"Targeting Microglial \u03b1-Synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson's Disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124420_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101202","article-title":"Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases","volume":"65","author":"Wu","year":"2021","journal-title":"Ageing Res. Rev."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526002298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526002298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:19:19Z","timestamp":1784708359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526002298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":81,"alternative-id":["S0024320526002298"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124420","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting P2X purinergic receptors with suramin alleviates rotenone-induced Parkinson's-like pathology via modulation of mitophagy and NLRP3-pyroptosis: Comparison with metformin","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124420"}}